Investment Research & Advisory Group’s Organon & Co OGN Stock Holding History

Investment Research & Advisory Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26	Closed	-$278	–	282
2025 Q3	$278	Hold	26	–	–	﹤0.01%	240
2025 Q2	$252	Hold	26	–	–	﹤0.01%	233
2025 Q1	$387	Buy	+26	New	+$400	﹤0.01%	241
2024 Q1	–	Sell	-1	Closed	-$14	–	227
2023 Q4	$14	Sell	1 -94	-99%	-$1.28K	﹤0.01%	221
2023 Q3	$1.65K	Sell	95 -110	-54%	-$2.29K	﹤0.01%	189
2023 Q2	$4.27K	Hold	205	–	–	﹤0.01%	184
2023 Q1	$4.82K	Hold	205	–	–	﹤0.01%	158
2022 Q4	$5.73K	Hold	205	–	–	﹤0.01%	156
2022 Q3	$5K	Hold	205	–	–	﹤0.01%	159
2022 Q2	$7K	Hold	205	–	–	0.01%	153
2022 Q1	$7K	Sell	205 -39	-16%	-$1.33K	﹤0.01%	164
2021 Q4	$7K	Buy	+244	New	+$7.95K	﹤0.01%	171

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Investment Research & Advisory Group's OGN Position: Q4 2025 in Review

Investment Research & Advisory Group sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 26 shares — an estimated $278 sold.

Investment Research & Advisory Group first reported a position in OGN in Q4 2021 and held it in 12 quarters. The position peaked at $7K in Q2 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

Investment Research & Advisory Group reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
Investment Research & Advisory Group sold 26 Organon & Co shares in Q4 2025, an estimated $278.
Investment Research & Advisory Group first reported a position in Organon & Co in Q4 2021 and held it in 12 quarters.
Investment Research & Advisory Group's Organon & Co position peaked at $7K in Q2 2022.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Investment Research & Advisory Group's 13F filing for Q4 2025, filed 20 Jan 2026.